CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation Statement Large-Bore Radial Access for Complex PCI: A Flash of COLOR With Some Shades of Grey Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure Assistance Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN CTO Registry Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education? Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association

Clinical Trial2018 Oct 27. [Epub ahead of print]

JOURNAL:J Am Coll Cardiol. Article Link

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial

M Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators. Keywords: Alirocumab; acute coronary syndrome; total events

FuLL TEXT PDF